Publication Name	World Journal of Stem Cells
Manuscript ID	108202
Country	Kazakhstan

Received	2025-04-08 13:19
Peer-Review Started	2025-04-08 13:19
To Make the First Decision
Return for Revision	2025-04-23 11:47
Revised	2025-05-01 06:11
Second Decision	2025-06-26 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-07-03 07:37
Articles in Press	2025-07-03 07:37
Publication Fee Transferred	2025-05-08 05:55
Edit the Manuscript by Language Editor	2025-07-06 20:07
Typeset the Manuscript	2025-07-15 14:51
Publish the Manuscript Online	2025-07-24 09:11

ISSN	1948-0210 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Meta-Analysis
Article Title	Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis
Manuscript Source	Unsolicited Manuscript
All Author List	Raisa A Aringazina, Afshin Zare, Seyyed Mojtaba Mousavi, Nurgul Abenova, Nadiar Maratovich Mussin and Amin Tamadon
ORCID	Author(s) ORCID Number Raisa A Aringazina http://orcid.org/0000-0003-1186-7796 Afshin Zare http://orcid.org/0000-0002-1932-8773 Amin Tamadon http://orcid.org/0000-0002-0222-3035
Funding Agency and Grant Number	Funding Agency Grant Number Clinical Variants of Metabolic Syndrome and Hormonal Mechanisms of its Formation in the Residents of Aktobe City 8/5-1-04/1-36/1
Corresponding Author	Amin Tamadon, Full Professor, PhD, Department of Natural Sciences, West Kazakhstan Marat Ospanov Medical University, No. 60 Maresiev Street, Aktobe 030012, Kazakhstan. amintamaddon@yahoo.com
Key Words	Type 2 diabetes mellitus; Metabolic disorders; Obesity; Insulin lessen; Insulin resistance; Cell therapy; Mesenchymal stem cell
Core Tip	This comprehensive review explores the potential of mesenchymal stem cell (MSC)-based therapies, both autologous and allogeneic, for treating type 2 diabetes mellitus. The study evaluates the safety, efficacy, and therapeutic benefits of MSCs, highlighting improvements in glycemic control, reductions in insulin requirements, and enhanced β-cell function. While MSC-based therapies show promising results with minimal adverse effects, challenges remain in standardizing treatment protocols. Future research should aim to refine these therapies and assess their long-term effects through large-scale clinical trials.
Publish Date	2025-07-24 09:11
Citation	<p>Aringazina RA, Zare A, Mousavi SM, Abenova N, Mussin NM, Tamadon A. Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis. <i>World J Stem Cells</i> 2025; 17(7): 108202</p>
URL	https://www.wjgnet.com/1948-0210/full/v17/i7/108202.htm
DOI	https://dx.doi.org/10.4252/wjsc.v17.i7.108202

Full Article (PDF)	WJSC-17-108202-with-cover.pdf
PRISMA 2009 Checklist	108202-PRISMA-2009-Checklist.pdf
Manuscript File	108202_Auto_Edited_074525.docx
Answering Reviewers	108202-answering-reviewers.pdf
Audio Core Tip	108202-audio.m4a
Biostatistics Review Certificate	108202-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form	108202-conflict-of-interest-statement.pdf
Copyright License Agreement	108202-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	108202-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate	108202-non-native-speakers.pdf
Supplementary Material	108202-supplementary-material.pdf
Peer-review Report	108202-peer-reviews.pdf
Scientific Misconduct Check	108202-scientific-misconduct-check.png
Scientific Editor Work List	108202-scientific-editor-work-list.pdf
CrossCheck Report	108202-crosscheck-report.pdf